Ground News

News from Baylor College of Medicine

Stay current with all the latest and breaking news from Baylor College of Medicine. Compare headlines and media bias behind news outlets on stories breaking today.

Overall, we’ve indexed 56 stories from Baylor College of Medicine over the past 3 months.

Baylor College of Medicine’s aggregated media bias check is unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, All Sides, and Media Bias/Fact Check.

We’ve assigned a rating of Unknown factuality to Baylor College of Medicine. You can read more about how we’ve determined Baylor College of Medicine’s credibility and reliability as a news source here: https://groundnews.lakegeneva.lib.wi.us/rating-system.

Information about Baylor College of Medicine

Where is Baylor College of Medicine located?Baylor College of Medicine's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Baylor College of Medicine News

Medical · Houston

Study reveals new indicators for HER2+ breast cancer response to therapy

100% Center coverage: 1 sources

Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible treatment. Their decision is informed by a comprehensive molecular profile of the patient's cancer samples that predicts the most likely response of the cancer to treatment.See the Story

Neogap Receives Approval to Administer Full Dose in Cell Therapy Trial for Colorectal Cancer - Pharmafile

Neogap Therapeutics has received regulatory approval from the Swedish Medical Products Agency to administer the full dose of its investigational cell therapy to all patients in its ongoing phase 1 and 2 trial for advanced colorectal cancer. The approval allows for a revised study protocol that removes the initial dose-escalation step, allowing all participants to […] The post Neogap receives approval to administer full dose in cell therapy trial…Houston, Texas · Houston See the Story

Page High School celebrates 50th commencement

67% Left coverage: 3 sources

Fred J. Page High School graduated its 50th class last Thursday evening with a commencement ceremony on the Page High Patriots football field.Faribault · Faribault See the Story

MODERN (A032103): Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder for Bladder Cancer Treatment

MODERN (A032103): Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder for Bladder Cancer Treatment Andrew Phifer Wed, 05/28/2025Houston, Texas · Houston Read Article

PARAMUNE Trial: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer

S2303 PARAMMUNE: Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients...Houston, Texas · Houston Read Article

ASCENT-GYN-01: Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer

A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer...Cancer · Houston Read Article

RMC-GI-102: Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

A Platform Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid TumorsThe purpose of this platform study is to...Houston, Texas · Houston Read Article

FORTE: Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

FORTE (NRG-CC005): Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous PolypsThis trial examines colorectal cancer...Cancer · Houston Read Article

S1937: Comparing Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

S1937: A Phase III Randomized Trial of Eribulin (NSC #707389) With Gemcitabine Versus Standard of Care (Physician's Choice) for Treatment of...Houston, Texas · Houston Read Article

News from Baylor College of Medicine

News from Baylor College of Medicine

Information about Baylor College of Medicine

Media Bias Ratings

Factuality

Ownership

Top Baylor College of Medicine News

Study reveals new indicators for HER2+ breast cancer response to therapy

Neogap Receives Approval to Administer Full Dose in Cell Therapy Trial for Colorectal Cancer - Pharmafile

Page High School celebrates 50th commencement

MODERN (A032103): Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder for Bladder Cancer Treatment

PARAMUNE Trial: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer

ASCENT-GYN-01: Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer

RMC-GI-102: Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

FORTE: Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

S1937: Comparing Eribulin With Chemotherapy Against the Usual Chemotherapy Alone in Metastatic Urothelial Cancer

Similar News Topics

Topics Most Covered by Baylor College of Medicine

Sources Covering Similar Topics

Breaking News Topics Related to Baylor College of Medicine